Sivakrishna
☆    

India,
2020-06-01 13:47
(1396 d 14:21 ago)

Posting: # 21494
Views: 1,884
 

 Regarding used normal Two-way crossover program was used for un-scaled average [Study As­sess­ment]

Dear All,

Good Afternoon,

One of my close friend asked the below query
Two-way cross over ANOVA model calculation was used for Unscaled average bio equivalence instead of Progesterone Guidelines program and study was submitted FDA regulatory. when he used the two-way crossover program study was met bio equivalence criteria (i.e., 80.00-125.00%). However, with the progesterone guidelines the study is not meeting Bio equivalence criteria for Cmax PK parameter (upper limit showing 126.14%). How can we justify this failure. please help to my friend.

Thanks in advance.

Thanks and Regards

G. Siva Krishna Teja.
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2020-06-01 17:08
(1396 d 11:00 ago)

@ Sivakrishna
Posting: # 21495
Views: 1,274
 

 (2×2×2?) ANOVA instead of mixed model

Hi Siva Krishna,

some hints:
  • I’m not sure whether I understand your subject line. For reference-scaling you need a replicate design and software which can handle that. If the software was designed for 2×2×2 only, it should throw an error (since the design is not supported).
  • The intention to apply reference-scaling should have been stated in the protocol (approved by the OGD).
  • If your friend planned to used ANOVA (i.e., fixed effects in suitable software) if swR <0.294, that’s a deviation from the guidance (requiring a mixed-effects model). Your friend should have contacted the OGD before the study. I doubt that the OGD would have accepted that.
  • By not doing so, your friend actually risked a Refuse-to-Receive (Section B) and was lucky that the OGD asked for a second evaluation according to the guidance.
  • In many cases the mixed model is more conservative than ANOVA. Hence, a wider CI with the former is not unusual.

❝ How can we justify this failure. please help to my friend.


Justify cherry-picking? Imagine you are an assessor. You have two evaluations on the desk. One deviating from the guidance – passing – and another one acc. to the guidance – failing. What would you do? Let’s reverse this game. You have another study passing acc. to the guidance and plan to submit it. Just for fun you assess it by an ANOVA and it fails. Would you present that? I doubt it.

P.S.: I suggest that you friend registers here. Possibly we have more questions and it’s more efficient to get background information directly than playing Chinese Whispers.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
90 visitors (0 registered, 90 guests [including 5 identified bots]).
Forum time: 03:09 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5